RICERCA
AUTORI
RIVISTE
Sfoglia per AUTORE
BONORA S
Collezione ASL Città di Torino
Items : 109
Switching to Low Neurotoxic Antiretrovirals to Improve Neurocognition Among People Living With HIV-1-Associated Neurocognitive Disorder: The MARAND-X Randomized Clinical Trial. in Journal of acquired immune deficiency syndromes (1999) / J Acquir Immune Defic Syndr. 2024 Oct 1;97(2):180-191. doi: 10.1097/QAI.0000000000003480.
2024
ASL Città di Torino
Calcagno A; Di Perri G; Bonora S; Trentalange A; Giaccone C; Trunfio M; Noce G; Ghisetti V; Tettoni MC; Nigra M; Guastamacchia G; Stroffolini G; Pirriatore V; Barco A; Vai D; Lazzaro A;
Symptomatic and Asymptomatic Neurocognitive Impairment, ART Adherence and HIV Control: A 4-Year Observational Study. in AIDS and behavior / AIDS Behav. 2024 Nov;28(11):3643-3654. doi: 10.1007/s10461-024-04440-w. Epub 2024 Jul 30.
2024
ASL Città di Torino
Vai D; Bonora S; Di Perri G; Calcagno A; Letendre SL; Cinnirella G; Imperiale D; Quarta C; Trunfio M; Vuaran E; Di Stefano A;
Intrathecal production of anti-Epstein-Barr virus viral capsid antigen IgG is associated with neurocognition and tau proteins in people with HIV. in AIDS (London, England) / AIDS. 2024 Mar 15;38(4):477-486. doi: 10.1097/QAD.0000000000003775. Epub 2023 Nov 7.
2024
AOU Città della Salute di Torino
ASL Città di Torino
Letendre SL; Calcagno A; Di Perri G; Cavallo R; Bonora S; Imperiale D; Croce M; Pittaluga F; Vai D; Trunfio M; Sacchi A;
Host single nucleotide polymorphisms and biomarkers of neuronal damage and inflammation in people living with HIV. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2024 Jun;63(6):107137. doi: 10.1016/j.ijantimicag.2024.107137. Epub 2024 Ma
2024
AOU Città della Salute di Torino
ASL Città di Torino
Calcagno A; D'Avolio A; Di Perri G; Trunfio M; Marinaro L; Bonora S; Avataneo V; Mula J; Antonucci M; Cusato J; Manca A; Palermiti A;
Studying the Changes in Physical Functioning and Oxidative Stress-Related Molecules in People Living with HIV after Switching from Triple to Dual Therapy. in Antioxidants (Basel, Switzerland) / Antioxidants (Basel). 2024 Apr 26;13(5):518. doi: 10.3390/antiox13050518.
2024
ASL Città di Torino
D'Avolio A; Di Perri G; Lupo C; Rainoldi A; Bonora S; Cuomo S; Trevisan G; Maddalone MG; Tettoni MC; Mula J; Bianco G; Chiara F; Accardo G; Palermiti A; Manca A; Antonucci M; Ferrara M; Cusato J; Mulasso A;
Sequential or Combination Treatments as Rescue Therapies in Immunocompromised Patients with Persistent SARS-CoV-2 Infection in the Omicron Era: A Case Series. in Antibiotics (Basel, Switzerland) / Antibiotics (Basel). 2023 Sep 19;12(9):1460. doi: 10.3390/antibiotics12091460.
2023
ASL Città di Torino
ASL Asti
Bonora S; Calcagno A; Frascione PMM; De Rosa FG; Gregorc V; Pepe A; Ponzetta L; Vita D; Allice T; Lupia T; Ranzani FA; Venuti F; Gaviraghi A; Longo BM;
COVID-19: Focusing on the Link between Inflammation, Vitamin D, MAPK Pathway and Oxidative Stress Genetics. in Antioxidants (Basel, Switzerland) / Antioxidants (Basel). 2023 May 20;12(5):1133. doi: 10.3390/antiox12051133.
2023
ASL Città di Torino
Calcagno A; D'Avolio A; Bonora S; Di Perri G; Maiese D; Ferrara M; Antonucci M; Chiara F; De Vivo ED; Costanzo M; Cusato J; Manca A; Mula J; Palermiti A;
Transient plasma viral rebound after SARS-CoV-2 vaccination in an exceptional HIV-1 elite controller woman. in Virology journal / Virol J. 2023 Jun 13;20(1):123. doi: 10.1186/s12985-023-02086-z.
2023
ASL Città di Torino
Bonora S; Calcagno A; Alladio F; Fantino S; Di Perri G; Burdino E; Allice T; Longo BM; Di Girolamo L; Ferrara M; Trevisan G;
Cerebrospinal Fluid CXCL13 as Candidate Biomarker of Intrathecal Immune Activation, IgG Synthesis and Neurocognitive Impairment in People with HIV. in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology / J Neuroimmune Pharmacol. 2023 Jun;18(1-2):169-182. doi: 10.1007/s11481-023-10066-x. Epub 2023 May 11
2023
ASL Città di Torino
Di Perri G; Bonora S; Guastamacchia G; Nigra M; Napoli L; Atzori C; Trunfio M; Mighetto L; Calcagno A;
Real-Life Experience of Continuously Infused Ceftolozane/Tazobactam in Patients with Bronchiectasis and Multidrug-Resistant Pseudomonas aeruginosa Infection in the Outpatient Setting. in Antibiotics (Basel, Switzerland) / Antibiotics (Basel). 2023 Jul 21;12(7):1214. doi: 10.3390/antibiotics12071214.
2023
ASL Città di Torino
Bonora S; Calcagno A; Marchiaro C; D'Avolio A; Cinnirella G; Catellani E; Romano F; Quaranta M; Ranzani FA; Di Vincenzo A; Stroffolini G; Gaviraghi A; Longo BM; De Nicolò A; Venuti F;
Antiretroviral Levels in the Cerebrospinal Fluid: The Effect of Inflammation and Genetic Variants. in Diagnostics (Basel, Switzerland) / Diagnostics (Basel). 2023 Jan 12;13(2):295. doi: 10.3390/diagnostics13020295.
2023
ASL Città di Torino
Mula J; Bonora S; D'Avolio A; Calcagno A; Di Perri G; Manca A; Palermiti A; Marinaro L; Trunfio M; Cusato J; Avataneo V; Antonucci M;
Changes in Cerebrospinal Fluid, Liver and Intima-media-thickness Biomarkers in Patients with HIV-associated Neurocognitive Disorders Randomized to a Less Neurotoxic Treatment Regimen. in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology / J Neuroimmune Pharmacol. 2023 Dec;18(4):551-562. doi: 10.1007/s11481-023-10086-7. Epub 2023 Oct 31.
2023
ASL Città di Torino
Calcagno A; Atzori C; Trunfio M; Di Perri G G; Bonora S; Barco A; Pirriatore V; Nigra M; Giaccone C; Vai D; Stroffolini G; Lazzaro A;
The presence of resistance-associated mutations in reverse transcriptase gene is associated with cerebrospinal fluid HIV-1 escape: A multicentric retrospective analysis. in Journal of medical virology / J Med Virol. 2023 Apr;95(4):e28704. doi: 10.1002/jmv.28704.
2023
ASL Città di Torino
Antinori A; Bonora S; Ghisetti V; D'Arminio Monforte A; Focà E; Vera JH; D'Ettorre G; Arsuffi S; Celani L; Bai F; Pinnetti C; Trunfio M; Calcagno A;
Antiretroviral Levels in the Cerebrospinal Fluid: The Effect of Inflammation and Genetic Variants in Diagnostics
2023
ASL Città di Torino
Palermiti A; Manca A; Di Perri G; Mula J; Bonora S; D’Avolio A; Calcagno A; Cusato J; Avataneo V; Antonucci M; Trunfio M; Marinaro L;
NEUROCOGNITIVE IMPAIRMENT NEGATIVELY AFFECTS VIRAL CONTROL IN ART-TREATED PWH in Topics in Antiviral Medicine
2023
ASL Città di Torino
Trunfio M; Vuaran E; Vai D; Di Stefano A; Imperiale D; Bonora S; Di Perri G; Calcagno A;
THE CEREBROSPINAL FLUID VIROME IN VIRALLY SUPPRESSED PEOPLE LIVING WITH HIV in Topics in Antiviral Medicine
2023
ASL Città di Torino
Trunfio M; Fox V; Scutari R; Fini V; Granaglia A; Russo C; Vuaran E; Imperiale D; Perno CF; Bonora S; Di Perri G; Alteri C; Calcagno A;
Real-life Evidence of Lower Lung Virulence in COVID-19 Inpatients Infected with SARS-CoV-2 Omicron Variant Compared to Wild-Type and Delta SARS-CoV-2 Pneumonia. in Lung / Lung. 2022 Oct;200(5):573-577. doi: 10.1007/s00408-022-00566-7. Epub 2022 Sep 17.
2022
ASL Città di Torino
Bonora S; Di Perri G; Trunfio M; Cortese G; Traverso F; Nespoli P; Vicinanza S; Portesani F; Calcagno A;
Trichinella britovi outbreak in Piedmont, North-West Italy, 2019-2020: Clinical and epidemiological insights in the one health perspective. in Travel medicine and infectious disease / Travel Med Infect Dis. 2022 May-Jun;47:102308. doi: 10.1016/j.tmaid.2022.102308. Epub 2022 Mar 9.
2022
ASL Città di Torino
ASL Asti
ASL Torino 4
ASL Torino 3
Di Perri G; Calleri G; Calcagno A; Bonora S; Lipani F; Paltrinieri G; Lupia T; Faraoni S; Stroffolini G; Rossi L;
Concurrent and Subsequent Co-Infections of Clostridioides difficile Colitis in the Era of Gut Microbiota and Expanding Treatment Options. in Microorganisms / Microorganisms. 2022 Jun 23;10(7):1275. doi: 10.3390/microorganisms10071275.
2022
ASL Città di Torino
AOU Città della Salute di Torino
Calcagno A; Di Perri G; Bonora S; Rugge W; Scabini S; Trunfio M;
Screening Accuracy of Mini Addenbrooke's Cognitive Examination Test for HIV-Associated Neurocognitive Disorders in People Ageing with HIV. in AIDS and behavior / AIDS Behav. 2022 Jul;26(7):2203-2211. doi: 10.1007/s10461-021-03563-8. Epub 2022 Jan 4.
2022
ASL Città di Torino
Calcagno A; Bonora S; Di Perri G; Imperiale D; Domini S; Alcantarini C; Trunfio M; Milesi M; Medina C; Vai D; De Francesco D;
Efflorescence of acquired epidermodysplasia verruciformis due to immune reconstitution inflammatory syndrome-like mechanisms following anti-HPV vaccination in a HIV-positive patient. in International journal of STD & AIDS / Int J STD AIDS. 2022 Jan;33(1):94-96. doi: 10.1177/09564624211048343. Epub 2021 Oct 11.
2022
ASL Città di Torino
Trunfio M; Parietti M; Delmonte S; Conti L; Trentalange A; Bonora S; Calcagno A; Ribero S;
Oral doxycycline in HIV-related synchronous malignant syphilis and condyloma lata. in Italian journal of dermatology and venereology / Ital J Dermatol Venerol. 2022 Dec;157(6):524-525. doi: 10.23736/S2784-8671.22.07232-2.
2022
AOU Città della Salute di Torino
ASL Città di Torino
Ribero S; Quaglino P; Fierro MT; Marra E; Senetta R; Conti L; Rugge W; Calleri G; Bonora S; Trunfio M; Susca S; Mastorino L; Cavallo F; Avallone G;
Sex-specific fat mass ratio cutoff value identifies a high prevalence of cardio-metabolic disorders in people living with HIV. in Nutrition, metabolism, and cardiovascular diseases : NMCD / Nutr Metab Cardiovasc Dis. 2022 Aug;32(8):1936-1943. doi: 10.1016/j.numecd.2022.05.004. Epub 2022 Ma
2022
ASL Città di Torino
AOU Città della Salute di Torino
Ghigo E; Di Perri G; Bonora S; Trentini L; Mazzetti R; Pusterla A; Maiorino F; Bioletto F; Massano M; Barale M; Procopio M;
Patterns of Cerebrospinal Fluid Alzheimer's Dementia Biomarkers in People Living with HIV: Cross-Sectional Study on Associated Factors According to Viral Control, Neurological Confounders and Neurocognition. in Viruses / Viruses. 2022 Apr 4;14(4):753. doi: 10.3390/v14040753.
2022
ASL Città di Torino
Calcagno A; Di Perri G; Bonora S; Vai D; Nigra M; Imperiale D; Di Stefano A; Atzori C; Pasquero M; Trunfio M;
Correlations between cerebrospinal fluid biomarkers, neurocognitive tests, and resting-state electroencephalography (rsEEG) in patients with HIV-associated neurocognitive disorders. in Journal of neurovirology / J Neurovirol. 2022 Apr;28(2):226-235. doi: 10.1007/s13365-021-01047-y. Epub 2022 Jan 19.
2022
ASL Città di Torino
Di Perri G; Calcagno A; Noce G; Atzori C; Trunfio M; Bonora S; Guastamacchia G; Lazzaro A; Vai D; Pirriatore V; Barco A; Orlando S; Stroffolini G;
The importance of Therapeutic Drug Monitoring during pregnancy in a HIV-positive woman taking lifelong antiretroviral therapy in Biochimica Clinica
2022
ASL Città di Torino
Cusato J; D'Avolio A; Di Perri G; Bonora S; Calcagno A; Antonucci M; Marinaro L;
2022
ASL Città di Torino
Guastamacchia G; Bonora S; Di Perri G; Calcagno A; Trunfio M; Mighetto L; Napoli L; Atzori C; Nigra M;
Determinants of SARS-CoV-2 Contagiousness in Household Contacts of Symptomatic Adult Index Cases. in Frontiers in microbiology / Front Microbiol. 2022 Apr 1;13:829393. doi: 10.3389/fmicb.2022.829393. eCollection 2022.
2022
ASL Città di Torino
Venuti F; Ghisetti V; Longo B; Staffilano E; Alladio F; Trunfio M; Richiardi L; Burdino E; Bonora S; Vineis P; Di Perri G; Calcagno A;
BCGitis after Bacille Calmette-Guerin intravesical administration from two referral centers: clinical characteristics and risk factors. in Le infezioni in medicina / Infez Med. 2022 Jun 1;30(2):242-246. doi: 10.53854/liim-3002-9. eCollection 2022.
2022
ASL Città di Torino
Di Perri G; Calcagno A; Bonora S; Lupia T; Bonfanti P; Lapadula G; Barco A; Rossi M; De Benedetto I;
Indirect hyperbilirubinemia and jaundice during chronic hepatitis C in an HIV-infected patient treated with glecaprevir/pibrentasvir (GLE/PIB) and antiretroviral therapy (ART). The first reported case in Italy in Journal of preventive medicine and hygiene
2022
ASL Città di Torino
Mastroianni A; Vangeli V; Greco S; Chidichimo L; Urso F; Mauro MV; Bonora S; DE Nicolò A; D'Avolio A;
Clinical Phenotype and Contagiousness of Early Breakthrough SARS-CoV-2 Infections after BNT162b2 COVID-19 mRNA Vaccine: A Parallel Cohort Study in Healthcare Workers. in Vaccines / Vaccines (Basel). 2021 Nov 23;9(12):1377. doi: 10.3390/vaccines9121377.
2021
ASL Città di Torino
Bonora S; Calcagno A; Di Perri G; Emanuele T; Burdino E; Ghisetti V; Verga F; Trunfio M;
The Longest Persistence of Viable SARS-CoV-2 With Recurrence of Viremia and Relapsing Symptomatic COVID-19 in an Immunocompromised Patient-A Case Study. in Open forum infectious diseases / Open Forum Infect Dis. 2021 Apr 28;8(11):ofab217. doi: 10.1093/ofid/ofab217. eCollection 2021 Nov.
2021
ASL Città di Torino
Sepulcri C; Dentone C; Mikulska M; Bruzzone B; De Maria A; Silvestri G; De Palma R; Sette A; Bonora S; Ballerini F; Zehender G; Di Biagio A; Orsi A; Bartalucci G; Delfino E; Altosole T; Parodi A; Bergna A; Bozzano F; Fenoglio D; Lai A; Bassetti M;
Development and Validation of an Up-to-Date Highly Sensitive UHPLC-MS/MS Method for the Simultaneous Quantification of Current Anti-HIV Nucleoside Analogues in Human Plasma. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2021 May 13;14(5):460. doi: 10.3390/ph14050460.
2021
ASL Città di Torino
Ianniello A; Manca A; De Nicolò A; Palermiti A; Calcagno A; Ferrara M; Antonucci M; Cusato J; Avataneo V; De Vivo E; Bonora S; De Rosa FG; Di Perri G; D'Avolio A;
Blood-Brain Barrier Impairment in Patients Living with HIV: Predictors and Associated Biomarkers. in Diagnostics (Basel, Switzerland) / Diagnostics (Basel). 2021 May 12;11(5):867. doi: 10.3390/diagnostics11050867.
2021
ASL Città di Torino
Di Perri G; Calcagno A; Imperiale D; Bonora S; Atzori C; Nigra M; Cusato J; Ghisetti V; Trunfio M; Caligaris G;
Rifampicin and Isoniazid Maximal Concentrations are Below Efficacy-associated Thresholds in the Majority of Patients: Time to Increase the Doses? in International journal of antimicrobial agents / Int J Antimicrob Agents. 2021 Mar;57(3):106297. doi: 10.1016/j.ijantimicag.2021.106297. Epub 2021 Fe
2021
ASL Città di Torino
Calcagno A; Di Perri G; Bonora S; Piccioni P; D'Avolio A; De Nicolò A; Barco A; Rossi G; Costa C; Pirriatore V; Antonucci M; Trentalange A; Motta I; Borgogno E;
The Manifesto of Pharmacoenosis: Merging HIV Pharmacology into Pathocoenosis and Syndemics in Developing Countries. in Microorganisms / Microorganisms. 2021 Jul 31;9(8):1648. doi: 10.3390/microorganisms9081648.
2021
ASL Città di Torino
AOU Città della Salute di Torino
Calcagno A; Castelnuovo B; Bonora S; Di Perri G; Pirriatore V; Alcantarini C; Rugge W; Mornese Pinna S; Scabini S; Trunfio M;
Lowering SARS-CoV-2 viral load might affect transmission but not disease severity in secondary cases. in The Lancet. Infectious diseases / Lancet Infect Dis. 2021 Jul;21(7):914-915. doi: 10.1016/S1473-3099(21)00205-X. Epub 2021 Apr 14.
2021
ASL Città di Torino
Trunfio M; Calcagno A; Bonora S; Di Perri G;
Low Tenofovir Plasma Exposure in HIV Oral Pre-exposure Prophylaxis Recipients with Gastrointestinal Disorders. in Antimicrobial agents and chemotherapy / Antimicrob Agents Chemother. 2021 Jan 1;65(1):e01902-20. doi: 10.1128/AAC.01902-20. Epub 2020 Oct 26
2021
ASL Città di Torino
Di Perri G; D'Avolio A; Bonora S; de Nicolò A; Gervasoni C; Mistrangelo M; Testi R; Cattaneo D; Calcagno A; Dal Conte I;
Older Age is Associated with Higher Dolutegravir Exposure in Plasma and Cerebrospinal Fluid of People Living with HIV. in Clinical pharmacokinetics / Clin Pharmacokinet. 2021 Jan;60(1):103-109. doi: 10.1007/s40262-020-00916-9.
2021
ASL Città di Torino
Gervasoni C; Borghetti A; Moltó J; Calcagno A; Milesi M; Valle M; Avataneo V; Alcantarini C; Pla-Junca F; Trunfio M; D'Avolio A; Di Giambenedetto S; Cattaneo D; Di Perri G; Bonora S;
Diagnostic SARS-CoV-2 Cycle Threshold Value Predicts Disease Severity, Survival, and Six-Month Sequelae in COVID-19 Symptomatic Patients. in Viruses / Viruses. 2021 Feb 11;13(2):281. doi: 10.3390/v13020281.
2021
ASL Città di Torino
Trunfio M; Venuti F; Alladio F; Longo BM; Burdino E; Cerutti F; Ghisetti V; Bertucci R; Picco C; Bonora S; Di Perri G; Calcagno A;
Co-infection with other respiratory pathogens in COVID-19 patients. in Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases / Clin Microbiol Infect. 2021 Feb;27(2):297-298. doi: 10.1016/j.cmi.2020.08.012. Epub 2020 Aug 19.
2021
ASL Città di Torino
Calcagno A; Di Perri G; Boglione L; Bonora S; Ghisetti V; Allice T; Trunfio M; Burdino E;
Risk for SARS-CoV-2 infection in healthcare workers, Turin, Italy in Emerging Infectious Diseases
2021
ASL Città di Torino
Lipani F; Nigra M; D'Avolio A; Bonora S; Di Perri G; Calcagno A; Ghisetti V; Emanuele T; Trunfio M; Faraoni S; Boglione L; Burdino E; Audagnotto S;
Blood–brain barrier impairment in patients living with hiv: Predictors and associated biomarkers in Diagnostics
2021
ASL Città di Torino
Nigra M; Atzori C; Imperiale D; Bonora S; Di Perri G; Calcagno A; Caligaris G; Trunfio M; Ghisetti V; Cusato J;
The use of less neurotoxic antiretrovirals: Secondary endpoints of the Marand-X study in Topics in Antiviral Medicine
2021
ASL Città di Torino
Bonora S; Di Perri G; Mighetto L; Marinaro L; Trunfio M; Noce G; Atzori C; Guastamacchia G; Stroffolini G; Barco A; Orlando S; Pirriatore V; Calcagno A;
On the SARS-CoV-2 "Variolation Hypothesis": No Association Between Viral Load of Index Cases and COVID-19 Severity of Secondary Cases. in Frontiers in microbiology / Front Microbiol. 2021 Mar 16;12:646679. doi: 10.3389/fmicb.2021.646679. eCollection 2021.
2021
ASL Città di Torino
Longo BM; Trunfio M; Alladio F; Venuti F; Cerutti F; Ghisetti V; Bonora S; Di Perri G; Calcagno A;
The impact of age on antiretroviral drug pharmacokinetics in the treatment of adults living with HIV in Expert Opinion on Drug Metabolism and Toxicology
2021
ASL Città di Torino
Trunfio M; Calcagno A; D’Avolio A; Di Perri G; Bonora S;
Low tenofovir plasma exposure in HIV oral pre-exposure prophylaxis recipients with gastrointestinal disorders in Antimicrobial Agents and Chemotherapy
2021
ASL Città di Torino
D'Avolio A; Di Perri G; Calcagno A; Dal Conte I; Cattaneo D; Testi R; Mistrangelo M; Gervasoni C; de Nicolò A; Bonora S;
A review of the potential mechanisms of neuronal toxicity associated with antiretroviral drugs. in Journal of neurovirology / J Neurovirol. 2020 Oct;26(5):642-651. doi: 10.1007/s13365-020-00874-9. Epub 2020 Jul 31.
2020
ASL Città di Torino
Calcagno A; Bonora S; Guastamacchia G; De Benedetto I; Trunfio M;
Dual antiretroviral therapies are effective and safe regimens in the central nervous system of neurologically symptomatic people living with HIV. in AIDS (London, England) / AIDS. 2020 Nov 1;34(13):1899-1906. doi: 10.1097/QAD.0000000000002601.
2020
ASL Città di Torino
Calcagno A; Di Perri G; Bonora S; Guastamacchia G; Vai D; Atzori C; Trunfio M; Borgogno E; Domini S; Nigra M; Mighetto L; Rugge W;
Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2020 May-Jun;38(3):529-532. Epub 2020 May 1.
2020
ASL Città di Torino
Roccatello D; Oddone V; Osella S; Piccioni P; Radin M; Navarra M; Natale G; Milone V; Massara C; Manno E; Livigni S; Giusti M; Imperiale D; Imperiale G; Crosasso P; De Iaco F; Di Perri G; Eandi M; Fenoglio R; Cozzi M; Converso M; Cinnirella G; Boaro D; Boero R; Bonora S; Calcagno A; Cecchi I; Baldovino S; Rossi D; et alii...
Presence of Epstein-Barr virus DNA in cerebrospinal fluid is associated with greater HIV RNA and inflammation. in AIDS (London, England) / AIDS. 2020 Mar 1;34(3):373-380. doi: 10.1097/QAD.0000000000002442.
2020
ASL Città di Torino
Calcagno A; Bonora S; Di Perri G; Ghisetti V; Lipani F; Gregori G; Pirriatore V; Gianella S; Mighetto L; Imperiale D; Audagnotto S; Milia MG; Atzori C; Lupia T;
Effectiveness of Switching to Darunavir/Cobicistat in Virologically Suppressed HIV-Positive Patients Receiving Ritonavir-Boosted Protease Inhibitor-Based Regimen: The "STORE" Study. in Journal of acquired immune deficiency syndromes (1999) / J Acquir Immune Defic Syndr. 2020 Jul 1;84(3):290-294. doi: 10.1097/QAI.0000000000002331.
2020
ASL Città di Torino
Sterrantino G; Menzaghi B; Cossu MV; Vergori A; Antinori A; Gori A; Rusconi S; Cattelan AM; Castelli F; Gianotti N; Orofino G; Ripamonti D; Savinelli S; Manzillo E; Santantonio TA; Celesia BM; Cauda R; Maserati R; d'Arminio Monforte A; Stingone C; Bonora S; Uglietti A; Termini R; Rucci F; Mancusi D;
Cerebral white matter Hyperintensities in HIV-positive patients. in Brain imaging and behavior / Brain Imaging Behav. 2020 Feb;14(1):10-18. doi: 10.1007/s11682-018-9966-1.
2020
ASL Città di Torino
Calcagno A; Di Perri G; Bonora S; Barco A; Nunnari G; Imperiale D; Cusato J; Tettoni M; Trentalange A; Prochet A;
Validation of a UHPLC-MS/MS Method to Quantify Twelve Antiretroviral Drugs within Peripheral Blood Mononuclear Cells from People Living with HIV. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2020 Dec 25;14(1):12. doi: 10.3390/ph14010012.
2020
ASL Città di Torino
Ferrara M; Ianniello A; De Nicolò A; Avataneo V; Cusato J; Antonucci M; De Vivo E; Waitt C; Calcagno A; Trentalange A; Muccioli G; Bonora S; Di Perri G; D'Avolio A;
Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection. in Thrombosis research / Thromb Res. 2020 Dec;196:432-434. doi: 10.1016/j.thromres.2020.09.039. Epub 2020 Oct 8.
2020
ASL Città di Torino
Calcagno A; Di Perri G; Bonora S; Roccatello D; Lipani F; Sciascia S; Trentalange A; Gaviraghi A; Alcantarini C; Marinaro L; Cabodi D; Salvador E; Trunfio M;
Safety and efficacy of daclatasvir at doses other than 60?mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA foundation cohorts. in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver / Dig Liver Dis. 2020 Apr;52(4):447-451. doi: 10.1016/j.dld.2019.12.007. Epub 2020 Jan 17.
2020
ASL Città di Torino
Bonora S; Tavelli A; Rossotti R; Cingolani A; Lo Caputo S; Saracino A; Soria A; Marinaro L; Uberti-Foppa C; Mussini C; Puoti M; d'Arminio Monforte A;
Pharmacogenetic determinants of kidney-associated urinary and serum abnormalities in antiretroviral-treated HIV-positive patients. in The pharmacogenomics journal / Pharmacogenomics J. 2020 Apr;20(2):202-212. doi: 10.1038/s41397-019-0109-x. Epub 2019 Oct 16.
2020
ASL Città di Torino
Calcagno A; Cusato J; Marinaro L; Avataneo V; Di Perri G; Bonora S;
Serum Trimethylamine-N-oxide Concentrations in People Living with HIV and the Effect of Probiotic Supplementation in International Journal of Antimicrobial Agents
2020
ASL Città di Torino
Calcagno A; Di Perri G; Celani L; Bonora S; D'Avolio A; Tettoni M; Lazzaro A; D'Ascenzo F; D'Ettorre G; De Nicolò A; Montrucchio C;
Early low-molecular-weight heparin administration is associated with shorter time to SARS-CoV-2 swab negativity. in Antiviral therapy / Antivir Ther. 2020;25(6):327-333. doi: 10.3851/IMP3377.
2020
ASL Città di Torino
Gaviraghi A; Salvador E; Trunfio M; Audagnotto S; Marinaro L; Motta I; Casciaro R; Ghisetti V; Fava C; Bonora S; Di Perri G; Calcagno A;
Pharmacogenetic markers able to predict lipid-related parameters in a cohort of ritonavir treated patients in Biochimica Clinica
2020
ASL Città di Torino
Palermiti A; Marinaro L; Avataneo V; De Nicolò A; D'Avolio A; Bonora S; Di Perri G; Cusato J; Calcagno A; Antonucci M;
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients. in Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases / Clin Microbiol Infect. 2019 Nov;25(11):1443-1446. doi: 10.1016/j.cmi.2019.07.004. Epub 2019 Jul 25.
2019
ASL Città di Torino
ASL VCO
AOU Novara
Di Biagio A; Bonora S; Monno L; Paolini E; Callegaro AP; Zoncada A; Pecorari M; Francisci D; Borghi V; Galli L; Vicenti I; Bruzzone B; Taramasso L; Ungaro R;
HIV-1 detection in the olfactory mucosa of HIV-1-infected participants. in AIDS (London, England) / AIDS. 2019 Mar 15;33(4):665-674. doi: 10.1097/QAD.0000000000002102.
2019
ASL Città di Torino
Calcagno A; Zanusso G; Bonora S; Di Perri G; Pirriatore V; Amasio E; Ghisetti V; Cassoni P; Kincer LP; Catera S; Imperiale D; Allice T; Trunfio M; Joseph SB; Bertero L;
Switch to dolutegravir and unboosted atazanavir in HIV-1 infected patients with undetectable viral load and long exposure to antiretroviral therapy. in AIDS (London, England) / AIDS. 2019 Jun 1;33(7):1256-1260. doi: 10.1097/QAD.0000000000002188.
2019
ASL Città di Torino
Castagna A; Rusconi S; Gulminetti R; Bonora S; Mazzola G; Quiros-Roldan ME; De Socio GV; Ladisa N; Carosella S; Cattelan A; Di Giambenedetto S; Mena M; Poli A; Galli L; Riva A;
Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate are not transported by Concentrative Nucleoside Transporter 2. in Diagnostic microbiology and infectious disease / Diagn Microbiol Infect Dis. 2019 Jun;94(2):202-204. doi: 10.1016/j.diagmicrobio.2018.07.001. Epub 20
2019
ASL Città di Torino
Cusato J; Calcagno A; De Nicolò A; Mogyorosi K; D'Avolio A; Di Perri G; Bonora S;
The "milky way" galaxy of HIV-related central nervous system immune reaction syndromes. in Journal of neurovirology / J Neurovirol. 2019 Dec;25(6):887-892. doi: 10.1007/s13365-019-00769-4. Epub 2019 Jun 18.
2019
ASL Città di Torino
Di Perri G; Bonora S; Taraglio S; Imperiale D; Audagnotto S; Boghi A; Manini C; Trentalange A; Trunfio M; Calcagno A;
Alzheimer's dementia cerebrospinal fluid biomarkers in hivpositive patients on cart in Topics in Antiviral Medicine
2019
ASL Città di Torino
Trunfio M; Martini C; Mighetto L; Vai D; Imperiale D; Bonora S; Di Perri G; Calcagno A;
Antiretrovirals concentrations in the olfactory mucosa of hivpositive patients in Topics in Antiviral Medicine
2019
ASL Città di Torino
Calcagno A; De Nicolò A; Trunfio M; Allice T; Imperiale D; Bartoli C; Ghisetti V; Amasio ME; D'Avolio A; Di Perri G; Bonora S;
Characterization of baseline factors associated with treatment outcome in HCV-infected patients naive to direct acting antivirals: particular focus on natural resistance in Digestive and Liver Disease
2019
ASL Città di Torino
Perno CF; Ceccherini-Silberstein F; Craxì A; Andreoni M; Baldanti F; Angelico M; Pasquazzi C; Parruti G; Lampertico P; Taliani G; Babudieri S; Rizzardini G; Pellicelli A; Puoti M; Paba P; Sarmati L; Borghi V; Lichtner M; Guarneri V; Siciliano M; Morisco F; Iapadre N; Maserati R; Bonora S; Micheli V; Boccaccio V; Galli S; Magni CF; Campoli R; et alii...
Evaluation of risk factors associated with failure to a first-line NS5A-containing regimen in HCV-infected patients naive to direct acting antivirals: Particular focus on natural resistance in Journal of Hepatology
2019
ASL Città di Torino
Silberstein FC; Perno CF; Mario A; Andreoni M; Parruti G; Pasquazzi C; Lampertico P; Taliani G; Rizzardini G; Babudieri S; Pellicelli A; Craxi A; Sarmati L; Puoti M; Paba P; Lichtner M; Andreone P; Siciliano M; Morisco F; Bonora S; Iapadre N; Maserati R; Boccaccio V; Micheli V; Galli S; Magni CF; Campoli R; Borghi V; Nicolini LA; et alii...
Evaluation of risk factors associated with failure to a first-line NS5A-containing regimen in HCV-infected patients naive to direct acting antivirals: Particular focus on natural resistance in Journal of Hepatology
2019
ASL Città di Torino
Ceccherini Silberstein F; Federico Perno C; Andreoni M; Mario A; Parruti G; Pasquazzi C; Lampertico P; Taliani G; Rizzardini G; Pellicelli A; Babudieri S; Craxi A; Puoti M; Sarmati L; Paba P; Lichtner M; Andreone P; Siciliano M; Morisco F; Iapadre N; Bonora S; Maserati R; Boccaccio V; Micheli V; Federico Magni C; Galli S; Campoli R; Borghi V; Ambra Nicolini L; et alii...
Malignant Melanoma in People Living with HIV/AIDS: Can We Know More, Can We Do Better? in AIDS reviews / AIDS Rev. 2019;21(2):65-75. doi: 10.24875/AIDSRev.19000038.
2019
ASL Città di Torino
Trunfio M; Ribero S; Bonora S; Di Perri G; Quaglino P; Calcagno A;
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison. in HIV medicine / HIV Med. 2018 May 30. doi: 10.1111/hiv.12628.
2018
ASL Città di Torino
Taramasso L; Di Biagio A; Maggiolo F; Tavelli A; Lo Caputo S; Bonora S; Zaccarelli M; Caramello P; Costantini A; Viscoli C; d'Arminio Monforte A; Cozzi-Lepri A;
Diagnostic accuracy of new and old cognitive screening tools for HIV-associated neurocognitive disorders. in HIV medicine / HIV Med. 2018 May 15. doi: 10.1111/hiv.12622.
2018
ASL Città di Torino
Di Perri G; Bonora S; Imperiale D; Audagnotto S; Orofino G; Tettoni MC; Livelli A; Alcantarini C; Vai D; Montrucchio C; Trunfio M; Calcagno A;
Undetectable antimicrobial plasma concentrations in an HIV-positive patient with protein-losing enteropathy and chylothorax during Mycobacterium genavense and Leishmania abdominal infections. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2018 Feb 1;73(2):546-548. doi: 10.1093/jac/dkx385.
2018
ASL Città di Torino
Motta I; Trunfio M; Calcagno A; Pirriatore V; Scabini S; Palazzo A; Audagnotto S; Fatiguso G; Liberini V; Bellò M; D'Avolio A; Di Perri G; Bonora S;
CNS-Targeted Antiretroviral Strategies: When Are They Needed and What to Choose. in Current HIV/AIDS reports / Curr HIV/AIDS Rep. 2018 Feb;15(1):84-91. doi: 10.1007/s11904-018-0375-2.
2018
ASL Città di Torino
Calcagno A; Barco A; Trunfio M; Bonora S;
Effect of ABCC2 and ABCG2 Gene Polymorphisms and CSF-to-Serum Albumin Ratio on Ceftriaxone Plasma and Cerebrospinal Fluid Concentrations. in Journal of clinical pharmacology / J Clin Pharmacol. 2018 Dec;58(12):1550-1556. doi: 10.1002/jcph.1266. Epub 2018 Jun 6.
2018
ASL Città di Torino
Allegra S; Cardellino CS; Fatiguso G; Cusato J; De Nicolò A; Avataneo V; Bonora S; D'Avolio A; Di Perri G; Calcagno A;
The outcome of HIV-positive late presenters according to detectable CMV DNA and anti-CMV treatment. in Antiviral therapy / Antivir Ther. 2018;23(5):451-456. doi: 10.3851/IMP3221.
2018
ASL Città di Torino
Montrucchio C; Audagnotto S; Lucchini A; Calcagno A; Bigliano P; Marinaro L; Alcantarini C; Ghisetti V; Di Perri G; Bonora S;
Comparison of resistance profiles among DAA-naive and DAAexperienced patients infected with HCV non-1 genotype in Italy in Journal of Hepatology
2018
ASL Città di Torino
Silberstein FC; Cento V; Perno CF; Andreoni M; Angelico M; Sarmati L; Parruti G; Pasquazzi C; Craxi A; Gaeta GB; Raimondo G; Taliani G; Ciaccio A; Sangiovanni V; Rendina MG; Pellicelli A; Gubertini GA; Babudieri S; Bonora S; Boglione L; D'ambrosio R; Vullo V; Rossetti B; Zazzi M; Puoti M; Maserati R; Ciancio A; Boccaccio V; Lleo A; et alii...
HIV-RNA in the olfactory mucosa of HIV-positive patients in Topics in Antiviral Medicine
2018
ASL Città di Torino
Trunfio M; Allice T; Bertero L; Imperiale D; Catera S; Pirriatore V; Di Perri G; Amasio ME; Cassoni P; Ghisetti V; Bonora S; Calcagno A;
Characterization of resistance profiles in HCV 2-3-4 DAA-naïve and DAA-experienced infected patients in Italy in Digestive and Liver Disease
2018
ASL Città di Torino
Ceccherini-Silberstein F; Perno CF; Cento V; Andreoni M; Angelico M; Parruti G; Sarmati L; Pasquazzi C; Craxì A; Gaeta GB; Raimondo G; Taliani G; Ciaccio A; Sangiovanni V; Pellicelli A; Rendina M; Gubertini G; Babudieri S; Bonora S; Boglione L; D'Ambrosio AR; Vullo V; Zazzi M; Rossetti B; Puoti M; Maserati R; Ciancio A; Boccaccio V; Lleo A; et alii...
Detectable cerebrospinal fluid JCV DNA in late-presenting HIV-positive patients: beyond progressive multifocal leukoencephalopathy? in Journal of neurovirology / J Neurovirol. 2017 Oct;23(5):763-767. doi: 10.1007/s13365-017-0549-5. Epub 2017 Jul 5.
2017
ASL Città di Torino
Di Perri G; Bonora S; Lipani F; Prochet A; Ghisetti V; Audagnotto S; Imperiale D; Milia MG; Scarvaglieri E; Mornese Pinna S; Calcagno A;
UPLC-MS/MS method for the simultaneous quantification of three new antiretroviral drugs, dolutegravir, elvitegravir and rilpivirine, and other thirteen antiretroviral agents plus cobicistat and ritonavir boosters in human plasma. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2017 May 10;138:223-230. doi: 10.1016/j.jpba.2017.02.002. Epub 2017 Feb 3.
2017
ASL Città di Torino
Simiele M; Ariaudo A; De Nicolò A; Favata F; Ferrante M; Carcieri C; Bonora S; Di Perri G; De Avolio A;
Blood Brain Barrier Impairment in HIV-Positive Naïve and Effectively Treated Patients: Immune Activation Versus Astrocytosis. in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology / J Neuroimmune Pharmacol. 2017 Mar;12(1):187-193. doi: 10.1007/s11481-016-9717-2. Epub 2016 Nov 8.
2017
ASL Città di Torino
Di Perri G; Imperiale D; Lipani F; Scarvaglieri E; Audagnotto S; Cardellino C; Ghisetti V; Atzori C; Romito A; Calcagno A; Bonora S;
Role of vitamin D pathway gene polymorphisms on rifampicin plasma and intracellular pharmacokinetics. in Pharmacogenomics / Pharmacogenomics. 2017 Jun;18(9):865-880. doi: 10.2217/pgs-2017-0176. Epub 2017 Jun 8.
2017
ASL Città di Torino
Allegra S; Fatiguso G; Calcagno A; Baietto L; Motta I; Favata F; Cusato J; Bonora S; Di Perri G; D'Avolio A;
Prevalence and predictors of long corrected QT interval in HIV-positive patients: a multicenter study. in Journal of cardiovascular medicine (Hagerstown, Md.) / J Cardiovasc Med (Hagerstown). 2017 Jul;18(7):539-544. doi: 10.2459/JCM.0000000000000436.
2017
AOU Città della Salute di Torino
ASL Città di Torino
Mancone M; Ballocca F; Grosso Marra W; Calcagno A; D'Ettorre G; Cannillo M; D'Ascenzo F; Gili S; Orofino G; Marruncheddu L; Lonni E; Cinque A; Vullo F; Ceccarelli G; Vilardi I; Sardella G; Vullo V; Moretti C; Fedele F; Bonora S; Gaita F;
Treating HIV Infection in the Central Nervous System. in Drugs / Drugs. 2017 Feb;77(2):145-157. doi: 10.1007/s40265-016-0678-9.
2017
ASL Città di Torino
Calcagno A; Di Perri G; Bonora S;
Efficacy, safety and pharmacokinetics of atazanavir (200mg twice daily) plus raltegravir (400mg twice daily) dual regimen in the clinical setting. in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology / J Clin Virol. 2017 Feb;87:30-36. doi: 10.1016/j.jcv.2016.11.015. Epub 2016 Dec 1.
2017
ASL Città di Torino
Marinaro L; Calcagno A; Ripamonti D; Cenderello G; Pirriatore V; Trentini L; Salassa B; Bramato C; Orofino G; D'Avolio A; Rizzi M; Di Perri G; Rusconi S; Bonora S;
Genetic Polymorphisms Affecting the Pharmacokinetics of Antiretroviral Drugs. in Clinical pharmacokinetics / Clin Pharmacokinet. 2017 Apr;56(4):355-369. doi: 10.1007/s40262-016-0456-6.
2017
ASL Città di Torino
Calcagno A; Cusato J; D'Avolio A; Bonora S;
Cerebrospinal fluid viral load and neopterin in HIV-positive patients with undetectable viraemia. in Antiviral therapy / Antivir Ther. 2017;22(6):539-543. doi: 10.3851/IMP3140. Epub 2017 Feb 15.
2017
ASL Città di Torino
Bonora S; Di Perri G; Ghisetti V; Imperiale D; Ecclesia S; Ferrara M; Romito A; Allice T; Motta I; Calcagno A;
High Incidence of Infections in HIV-positive Patients Treated for Lymphoproliferative Disorders. in Current HIV research / Curr HIV Res. 2017;15(4):258-265. doi: 10.2174/1570162X15666170531085838.
2017
ASL Città di Torino
Sordella F; Bracchi M; Balbiano R; Caracciolo D; Lucchini A; Calcagno A; Gregori G; Lipani F; Audagnotto S; Chiriotto M; Cavaglia G; Ghisetti V; Di Perri G; Bonora S;
Additional screening tests for HIV-associated neurocognitive disorders in Topics in Antiviral Medicine
2017
ASL Città di Torino
Trunfio M; Montrucchio C; Vai D; Imperiale D; Livelli A; Orofino G; Trentalange A; Bonora S; Di Perri G; Calcagno A;
Discordant HIV RNA in olfactory mucosa of HIV-positive patients in Topics in Antiviral Medicine
2017
ASL Città di Torino
Calcagno A; Allice T; Bertero L; Trunfio M; Amasio ME; Imperiale D; Ghisetti V; Di Perri G; Cassoni P; Bonora S;
Socioeconomic status and biomedical risk factors in migrants and native tuberculosis patients in Italy. in PloS one / PLoS One. 2017 Dec 18;12(12):e0189425. doi: 10.1371/journal.pone.0189425. eCollection 2017.
2017
ASL Città di Torino
Contini S; Gualano G; Alma MG; Tadolini M; Piccioni P; Bocchino M; Matteelli A; Bonora S; Di Biagio A; Franzetti F; Carbonara S; Gori A; Sotgiu G; Palmieri F; Girardi E; Ippolito G; Piselli P; Pittalis S;
2017
ASL Città di Torino
Craxi A; Taliani G; Raimondo G; Ciaccio A; Sangiovanni V; Cariti G; Bonora S; Aghemo A; Vullo V; Foroghi L; Calvaruso V; Morisco F; Lleo A; Ciancio A; Maserati R; Brancaccio G; Puoti M; Toniutto P; Pollicino T; Paolucci S; Coppola N; Ruggiero T; Bruzzone B; Palitti VP; Gianserra L; Polilli E; Teti E; Lenci I; Aragri M; et alii...
PrEP in Italy: The time may be ripe but who's paying the bill? A nationwide survey on physicians' attitudes towards using antiretrovirals to prevent HIV infection. in PloS one / PLoS One. 2017 Jul 20;12(7):e0181433. doi: 10.1371/journal.pone.0181433. eCollection 2017.
2017
ASL Città di Torino
Di Biagio A; Riccardi N; Signori A; Maserati R; Nozza S; Gori A; Bonora S; Borderi M; Ripamonti D; Rossi MC; Orofino G; Quirino T; Nunnari G; Celesia BM; Martini S; Sagnelli C; Mazzola G; Colletti P; Bartolozzi D; Bini T; Ladisa N; Castelnuovo F; Saracino A; Lo Caputo S;
Blood brain barrier impairment is associated with cerebrospinal fluid markers of neuronal damage in HIV-positive patients. in Journal of neurovirology / J Neurovirol. 2016 Feb;22(1):88-92. doi: 10.1007/s13365-015-0371-x. Epub 2015 Aug 6.
2016
ASL Città di Torino
Di Perri G; Imperiale D; Montrucchio C; Stella ML; Audagnotto S; Vai D; Atzori C; Romito A; Calcagno A; Bonora S;
Efavirenz pharmacogenetics in a cohort of Italian patients. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2016 Feb;47(2):117-23. doi: 10.1016/j.ijantimicag.2015.11.012. Epub 2015 De
2016
ASL Città di Torino
Di Perri G; Leggieri A; Allegra S; Marinaro L; Bonora S; Calcagno A; Simiele M; Tomasello C; Cusato J; D'Avolio A;
Clearance of cerebrospinal fluid JCV DNA with mirtazapine in a patient with progressive multifocal leukoencephalopathy and sarcoidosis. in Antiviral therapy / Antivir Ther. 2016;21(7):633-635. doi: 10.3851/IMP3032. Epub 2016 Feb 9.
2016
ASL Città di Torino
Bonora S; Busolli P; Atzori C; Ghisetti V; Calcagno A; Trentalange A; Imperiale D;
Cerebrospinal fluid and plasma biomarkers in patients with HIV-associated neurocognitive disorders in Journal of the International AIDS Society
2016
ASL Città di Torino
Trunfio M; Vai D; Romito A; Atzori C; Imperiale D; Audagnotto S; Montrucchio C; Scabini S; Cardellino C; Pirriatore V; Di Perri G; Bonora S; Calcagno A;
High prevalence at computed coronary tomography of non-calcified plaques in asymptomatic HIV patients treated with HAART: a meta-analysis. in Atherosclerosis / Atherosclerosis. 2015 May;240(1):197-204. doi: 10.1016/j.atherosclerosis.2015.03.019. Epub 2015 Mar
2015
ASL Città di Torino
Abbate A; Bonora S; De Marie D; Escaned J; Estrada V; Garabello D; Mancone M; Salera D; Raviola A; Mistretta E; Pianelli M; Cannillo M; Gili S; Barbero U; Veglia S; Montefusco A; Omedè P; Ballocca F; Grossomarra W; Calcagno A; Cerrato E; D'Ascenzo F; Zoccai GB; Moretti C; Gaita F;
Cytomegalovirus central nervous system compartmentalization in a patient presenting with AIDS in Antiviral Therapy
2015
ASL Città di Torino
Trentalange A; Calcagno A; Raviolo S; Prochet A; Audagnotto S; Ghisetti V; Perri GD; Bonora S;
Cardiovascular disease in HIV patients: from bench to bedside and backwards. in Open heart / Open Heart. 2015 Mar 20;2(1):e000174. doi: 10.1136/openhrt-2014-000174. eCollection 2015.
2015
ASL Città di Torino
Escaned J; Estrada V; DiNicolantonio JJ; Bonora S; Abbate A; Omedè P; Demarie D; Grosso Marra W; Mancone M; Biondi-Zoccai G; D'Ascenzo F; Calcagno A; Cerrato E; Moretti C; Gaita F;
Cerebrospinal fluid biomarkers in patients with plasma HIV RNA below 20 copies/mL. in Journal of the International AIDS Society / J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19719. doi: 10.7448/IAS.17.4.19719. eCollection 2014.
2014
ASL Città di Torino
Di Perri G; Trentalange A; Alberione MC; Audagnotto S; Imperiale D; Ecclesia S; Romito A; Atzori C; Calcagno A; Bonora S;
Prevalence and predictors of blood-brain barrier damage in the HAART era in Journal of NeuroVirology
2014
ASL Città di Torino
Calcagno A; Alberione MC; Romito A; Imperiale D; Ghisetti V; Audagnotto S; Lipani F; Raviolo S; Di Perri G; Bonora S;
Thrombotic events and plaque progression in HIV-infected patients with ACS: Insights from an international contemporary registry in EuroIntervention
2013
ASL Città di Torino
Cerrato E; D'Ascenzo F; Appleton D; Moretti C; Calcagno A; Abouzaki N; Vetrovec G; Lhermusier T; Das Neves B; Escaned J; Cassese S; Kastrati A; Chinaglia A; Belli R; Capodanno D; Tamburino C; Santilli F; Parruti G; Parodi G; Vignali L; Mancone M; Sardella G; Fedele F; Omedè P; Bonora S; Abbate A; Biondi-Zoccai G; Gaita F;
2011
ASL Città di Torino
Calcagno A; Bonora S; Simiele M; Rostagno R; Tettoni MC; Bonasso M; Romito A; Imperiale D; D'Avolio A; Di Perri G;
Tenofovir and emtricitabine CSF-to-plasma ratios correlate to the extent of blood-brain-barrier damage in Infection
2011
ASL Città di Torino
Calcagno A; Bonora S; Simiele M; Audagnotto S; Siccardi M; De Requena DG; Romito A; Imperiale D; D'Avolio A; Di Perri G;
The effect of antituberculosis treatment on interferon-? release assay results in Monaldi Archives for Chest Disease - Pulmonary Series
2011
ASL Città di Torino
Bugiani M; Bonora S; Carosso A; Piccioni P; Cavallero M; Mondo A; Ghisetti V;
Maraviroc is a substrate for OATP1B1 in vitro and maraviroc plasma concentrations are influenced by SLCO1B1 521 T>C polymorphism in Pharmacogenetics and Genomics
2010
ASL Città di Torino
Siccardi M; D'Avolio A; Nozza S; Simiele M; Baietto L; Stefani FR; Moss D; Kwan W-S; Castagna A; Lazzarin A; Calcagno A; Bonora S; Back D; Di Perri G; Owen A;